Charles StaceyPresident & CEO at CerecinSpeaker
Profile
Dr. Charles Stacey is a physician, entrepreneur, and biotech leader specialising in the field of neuroscience and brain health. As President and CEO of Cerecin, he leads the development of breakthrough therapeutics that address metabolic targets in neurological diseases. Before Cerecin, Dr Stacey was part of Inventages, a venture capital group managing $1.5B in global health investments on behalf of the Nestle group. He has founded and led medical technology companies, and began his career as a trauma and reconstructive surgeon after earning his medical degree from King’s College London and a bachelor’s in neuroscience from UCL. He also holds an MBA from the London Business School.
In addition to his leadership at Cerecin, Charles is an active investor and advisor to early-stage life science companies. Passionate about innovation and driven by human impact, he is focused on innovating for impact.
Agenda Sessions
Innovation Without Borders: Cross-Border Collaboration Advancing APAC's Biotech Future
, 10:40View Session